SIO Central : September 2021 MSK Webinar CME Information

Continuing Medical Education Information

This activity is jointly provided by The France Foundation and the Society of Interventional Oncology.

Target Audience:

This educational activity is intended for interventional radiologists and other healthcare professionals who are looking to begin and/or expand their practice in musculoskeletal (MSK) interventions.

Statement of Need:

“Growing Your Practice: MSK for the Non-MSK Practitioner” is a 90-minute enduring activity intended to provide practical knowledge and insights on best practice for interventional radiologists looking to begin and/or expand their practice in musculoskeletal (MSK) interventions. The enduring activity targets interventional radiologists at any stage of their career, from senior-level physicians to students/trainees.

Educational Activity Learning Objectives:

Upon completion of this course, the participants should be able to:

Describe optimal techniques and processes to optimize musculoskeletal biopsy yield
Discuss factors that are important for identifying appropriate patients for musculoskeletal interventions
Review knowledge of various pain syndromes and percutaneous techniques for pain management
Explain strategies that will enable successful building of a musculoskeletal interventions practice

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The France Foundation and the Society of Interventional Oncology. The France Foundation is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation:

Physicians:

The France Foundation designates each enduring course for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Method of Participation/How to Receive Credit:

Review the activity objectives and CME/CE information.
Participate in the CME/CE activity.
Complete the CME/CE evaluation form, which provides each participant with the opportunity to comment on how participating in the activity will affect their professional practice; the quality of the instructional process; the perception of enhanced professional effectiveness; the perception of commercial bias; and his/her views on future educational needs.
If you are requesting educational credits or a certificate of participation, your certificate will be available for download.

Disclosure Policy:

In accordance with the ACCME Standards for Commercial Support, The France Foundation (TFF) and the Society of Interventional Oncology (SIO) require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TFF and SIO resolve all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational programs. Furthermore, TFF and SIO seek to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. TFF and SIO are committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of a commercial interest.

Activity Staff Disclosures:

The planners, reviewers, editors, staff, CME committee, or other members at The France Foundation who control content have no relevant financial relationships to disclose.

The planners, reviewers, editors, staff, CME committee, or other members at the Society of Interventional Oncology who control content have no relevant financial relationships to disclose.

Planning Committee Disclosures:

The planning committee members listed below report have disclosed the following:

Name and Affiliation	Role in Activity	Name of Commercial Entity	Nature of Relationship(s)	Mechanism(s) implemented to resolve conflict of interest appropriate to role(s) in the activity
Yosef Golowa, MD Montefiore Medical Center	Planning Committee Member	1. Angiodynamics	1. Non-CE Consulting, Non-CE Speakers Bureau	1.Other planning committee members served as content reviewers during planning meetings and correspondence
AJ Gunn, MD University of Alabama at Birmingham	Planning Committee Member	1.Boston Scientific, Varian 2.Boston Scientific, Varian, Terumo 3.Penumbra, Boston Scientific	1.Non-CE Consulting 2.Non-CE Speakers Bureau 3.Contract Research	1-3. Other planning committee members served as content reviewers during planning meetings and correspondence
Jonathan Kessler, MD City of Hope Medical Group	Planning Committee Member	1. Angiodynamics	1. Non-CE Speakers Bureau	1.Other planning committee members served as content reviewers during planning meetings and correspondence
Charles Kim, MD, FSIR Duke University Medical Center	Planning Committee Member	1. Boston Scientific, Becton Dickinson, ACI/Humacyte	1.Non-CE Consulting	1. Other planning committee members served as content reviewers during planning meetings and correspondence
Sirish Kishore, MD Memorial Sloan Kettering Cancer Center	Planning Committee Member	1. Inari Medical, Trisalus Life Sciences 2. Boston Scientific	1,Non-CE Consulting 2.Research	1-2. Other planning committee members served as content reviewers during planning meetings and correspondence
Richard Marshall, MD Louisiana State University	Planning Committee Member	1.Cardiovascular Systems Incorporated	1.Non-CE Speakers Bureau	1. Other planning committee members served as content reviewers during planning meetings and correspondence
Rob Suh, MD Ronald Regan UCLA Medical Center	Planning Committee Member	1.Neuwave Medical; Boehringer Ingelheim, Boston Scientific	1.Non-CE Speakers Bureau	1. Other planning committee members served as content reviewers during planning meetings and correspondence
Sean Tutton, MD, FSIR Medical College of Wisconsin	Planning Committee Member	1.Stryker, Varian 2.Siemens	1.Non-CE Consulting 2.Non-CE Speakers Bureau, Contract Research	1-2. Other planning committee members served as content reviewers during planning meetings and correspondence
Sarah White, MD, MS Medical College of Wisconsin	Planning Committee Member	1.Cook, Guerbet, NCT 2. Penumbra	1.Non-CE Consulting 2.Non-CE Speakers Bureau	1-2. Other planning committee members served as content reviewers during planning meetings and correspondence

The planning committee members listed below report that they have no relevant financial relationships to disclose:

Salim Abboud, MD, University Hospitals Cleveland Medical Center
Zachary Berman, MD, University of California San Diego
Ahmad Hashmi, MD, University Hospitals Cleveland Medical Center
Gina Landinez, MD, University of California San Francisco
Vladimir Sheynzon, MD, MBA, New York Presbyterian Hospital

Faculty Disclosures:

The faculty listed below report have disclosed the following:

Name and Affiliation

Role in Activity

Name of Commercial Entity

Nature of Relationship(s)

Mechanism(s) implemented to resolve conflict of interest appropriate to role(s) in the activity

Jason Levy, MD, FSIR, Northside Radiology

Presenter

1. Medtronic, Varian, Ebix

2. Medtronic, Sirtex

1.Non-CE Consulting

2.Non-CE Speakers Bureau

1-2. Planning committee reviewed content

Rahul Sheth, MD

MD Anderson Cancer Center

Presenter

1. Boston Scientific, Medtronic

1. Non-CE Consulting

1. Planning committee reviewed content

The faculty listed below report that they have no relevant financial relationships to disclose:

Junjian Huang, MD, University of Alabama at Birmingham
Anthony Tardos, MD, University of California San Diego

Commercial Support Disclosures:

This activity is supported by an educational grant from Varian Medical Systems, Inc.

Disclosure of Unlabeled Use:

TFF and SIO require CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. TFF and SIO do not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.

Disclaimer:

The France Foundation and the Society of Interventional Oncology present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation and the Society of Interventional Oncology assume no liability for the information herein.